ECHELON MedTech develops dual-use medical technologies that enhance health outcomes for service members, veterans, and civilians by addressing critical health challenges faced in both military and civilian settings. The company utilizes a proprietary technology assessment model to evaluate and commercialize medical devices, ensuring they meet the needs of diverse markets while achieving regulatory compliance.
Funding
Funding not disclosed
Founders
Product
Problem
Both military personnel and civilians face significant health challenges that require innovative medical solutions. Existing medical technologies may not adequately address the specific needs of both populations, leading to suboptimal health outcomes.
Solution
ECHELON MedTech develops and commercializes "dual-use" medical technologies designed to improve health outcomes for both service members/veterans and the general public. The company identifies promising medical device innovations and accelerates their development for commercial readiness. ECHELON utilizes a proprietary technology assessment model to evaluate potential technologies, considering factors such as market need, intellectual property strength, and the likelihood of successful commercialization. The company focuses on de-risking and demonstrating the commercial value proposition of these technologies through customer research, regulatory clearance, and manufacturing scale-up.
Target Audience
The primary target audience includes strategic market leaders seeking to acquire or partner with a technology developer, as well as the Department of Defense and civilian healthcare markets.
Features
- Proprietary technology assessment model evaluating market need, IP, and commercialization potential.
- Focus on technologies at Technology Readiness Level (TRL) 3 or 4, with demonstrated proof-of-concept.
- Development and de-risking of medical device innovations for both military and civilian applications.
- Facilitation of FDA clearance and manufacturing scale-up.
- Identification of market opportunities within the Department of Defense and civilian sectors.